Ledger.Open graph →
SEC Form D · filed June 8, 2016

Oncternal Therapeutics, Inc

Offering
$13.1M
Sold
$13.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Del Mar, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Dana F. Mcgowan · Del Mar, CAExecLauren G. Otsuki · Del Mar, CAExecJames G. Freddo · Del Mar, CAExecDavid F. Hale · Del Mar, CADirectorScott F. Glenn · Del Mar, CADirectorCam F. Garner · Del Mar, CADirectorJames B. Breitmeyer, M.D., Ph.D · Del Mar, CAExec · DirectorKaren F. Lundgren · Del Mar, CAExecDavid F. Johnson · Del Mar, CADirectorDana F. Mcgowan · Del Mar, CAExecKaren F. Lundgren · Del Mar, CAExecLauren G. Otsuki · Del Mar, CAExecJames G. Freddo · Del Mar, CAExecDavid F. Hale · Carlsbad, CADirectorScott F. Glenn · Del Mar, CADirectorCam F. Garner · Del Mar, CADirectorJames B. Breitmeyer, M.D., Ph.D · Del Mar, CAExec · DirectorDavid F. Johnson · Del Mar, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗